When asked whether or not he thought 7-year-old Josh Hardy should receive lifesaving treatment, a member of the board of directors at Chimerix seemed to blame government regulation for the company’s reluctance to give Josh access to their drug Brincidofovir.
“Don’t you people realize there is an FDA? We have done what we can. Say a prayer for Josh,” Tim Wollaeger wrote in an email to FoxNews.com.
The snarky remark came just hours after Chimerix announced it would begin a pilot trial for Brincidofovir – an antiviral drug that has been proven to clear up adenovirus in children within two weeks.